These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 2989312

  • 1. Radioimmunoassay and enzyme-linked immunoassay of antibodies to the core protein (P24) of human T-lymphotropic virus (HTLV III).
    Neurath AR, Strick N, Sproul P, Baker L, Rubinstein P, Stevens CE, Taylor P, Gallo RC, Gold JW, Lee YS.
    J Virol Methods; 1985 May; 11(1):75-86. PubMed ID: 2989312
    [Abstract] [Full Text] [Related]

  • 2. Radioimmunoassay and enzyme-linked immunoassay of antibodies directed against lymphadenopathy-associated virus (LAV) proteins larger than the core protein (P24).
    Neurath AR, Strick N, Lee YS, Nilsen T, Baker L, Sproul P, Rubinstein P, Taylor P, Stevens CE, Gold JW.
    J Virol Methods; 1985 Oct; 12(1-2):85-92. PubMed ID: 3001122
    [Abstract] [Full Text] [Related]

  • 3. Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men.
    Jaffe HW, Feorino PM, Darrow WW, O'Malley PM, Getchell JP, Warfield DT, Jones BM, Echenberg DF, Francis DP, Curran JW.
    Ann Intern Med; 1985 May; 102(5):627-8. PubMed ID: 2984973
    [Abstract] [Full Text] [Related]

  • 4. Serological characterization of HTLV-III infection in AIDS and related disorders.
    Groopman JE, Chen FW, Hope JA, Andrews JM, Swift RL, Benton CV, Sullivan JL, Volberding PA, Sites DP, Landesman S.
    J Infect Dis; 1986 Apr; 153(4):736-42. PubMed ID: 3005434
    [Abstract] [Full Text] [Related]

  • 5. Human T-cell lymphotropic virus type III: immunologic characterization and primary structure analysis of the major internal protein, p24.
    Casey JM, Kim Y, Andersen PR, Watson KF, Fox JL, Devare SG.
    J Virol; 1985 Aug; 55(2):417-23. PubMed ID: 2410630
    [Abstract] [Full Text] [Related]

  • 6. Retroviruses associated with leukemia and ablative syndromes in animals and in human beings.
    Essex M, McLane MF, Kanki P, Allan J, Kitchen L, Lee TH.
    Cancer Res; 1985 Sep; 45(9 Suppl):4534s-4538s. PubMed ID: 2990682
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood.
    Esteban JI, Shih JW, Tai CC, Bodner AJ, Kay JW, Alter HJ.
    Lancet; 1985 Nov 16; 2(8464):1083-6. PubMed ID: 2865566
    [Abstract] [Full Text] [Related]

  • 10. Seroepidemiology of HTLV-III (LAV) in the Federal Republic of Germany.
    Hunsmann G, Schneider J, Bayer H, Kurth R, Werner A, Brede HD, Erfle V, Mellert W, Brodt HR, Bergmann L.
    Klin Wochenschr; 1985 Mar 01; 63(5):233-5. PubMed ID: 2985862
    [Abstract] [Full Text] [Related]

  • 11. New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM).
    Kanki PJ, Barin F, M'Boup S, Allan JS, Romet-Lemonne JL, Marlink R, McLane MF, Lee TH, Arbeille B, Denis F.
    Science; 1986 Apr 11; 232(4747):238-43. PubMed ID: 3006256
    [Abstract] [Full Text] [Related]

  • 12. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
    Rook AH, Lane HC, Folks T, McCoy S, Alter H, Fauci AS.
    J Immunol; 1987 Feb 15; 138(4):1064-7. PubMed ID: 3027168
    [Abstract] [Full Text] [Related]

  • 13. Human retroviral env and gag polypeptides: serologic assays to measure infection.
    Kanner SB, Cheng-Mayer C, Geffin RB, Parks WP, Beltz GA, Arthur LO, Samuel KP, Papas TS.
    J Immunol; 1986 Jul 15; 137(2):674-8. PubMed ID: 3014000
    [Abstract] [Full Text] [Related]

  • 14. Detection of human T-cell lymphotropic virus type III-related antigens and anti-human T-cell lymphotropic virus type III antibodies by anticomplementary immunofluorescence.
    Blumberg RS, Sandstrom EG, Paradis TJ, Neumeyer DN, Sarngadharan MG, Hartshorn KL, Byington RE, Hirsch MS, Schooley RT.
    J Clin Microbiol; 1986 Jun 15; 23(6):1072-7. PubMed ID: 2423552
    [Abstract] [Full Text] [Related]

  • 15. Introduction of lymphadenopathy associated virus or human T lymphotropic virus (LAV/HTLV-III) into the male homosexual community in Amsterdam.
    Coutinho RA, Krone WJ, Smit L, Albrecht-van Lent P, van der Noordaa J, Schaesberg W, Goudsmit J.
    Genitourin Med; 1986 Feb 15; 62(1):38-43. PubMed ID: 3005159
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS.
    Kalyanaraman VS, Cabradilla CD, Getchell JP, Narayanan R, Braff EH, Chermann JC, Barré-Sinoussi F, Montagnier L, Spira TJ, Kaplan J.
    Science; 1984 Jul 20; 225(4659):321-3. PubMed ID: 6330889
    [Abstract] [Full Text] [Related]

  • 18. HTLV-III: the etiologic agent of AIDS.
    Sarngadharan MG, DeVico AL, Bruch L, Schüpbach J, Gallo RC.
    Princess Takamatsu Symp; 1984 Jul 20; 15():301-8. PubMed ID: 6100648
    [Abstract] [Full Text] [Related]

  • 19. Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses.
    Nara PL, Robey WG, Arthur LO, Asher DM, Wolff AV, Gibbs CJ, Gajdusek DC, Fischinger PJ.
    J Virol; 1987 Oct 20; 61(10):3173-80. PubMed ID: 2442411
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain.
    Cheingsong-Popov R, Weiss RA, Dalgleish A, Tedder RS, Shanson DC, Jeffries DJ, Ferns RB, Briggs EM, Weller IV, Mitton S.
    Lancet; 1984 Sep 01; 2(8401):477-80. PubMed ID: 6147546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.